$SYK

Global healthcare computer vision market projected to surge from $4.37B in 2026 to $33.4B by 2036, driven by AI diagnostics and radiologist shortages.

Stryker completes acquisition of Boston-based Amplitude Vascular Systems, adding next-generation intravascular lithotripsy technology to peripheral vascular offerings.

Stryker raises quarterly dividend 4.8% to $0.88/share, payable July 2026. Q1 net sales reached $6.0 billion, up 2.6% year-over-year.

$BDX trades at significant discount despite 60% infusion pump dominance, 90%+ recurring revenue, and $4B capital deployment driving billion-dollar growth platforms.

Global laparoscopy devices market projected to reach USD 23.5B by 2034 from USD 11.1B in 2025, growing at 9% CAGR amid rising minimally invasive surgery demand.

Global surgical drill bits market to grow from $316M in 2025 to $540M by 2035 at 5.5% CAGR, driven by infrastructure development and rising surgical volumes.

Global foot and ankle devices market projected to surge from $5.9B in 2025 to $9.2B by 2034, driven by aging populations and diabetes complications.

Global ambulatory surgical equipment market projected to double from $7.39B in 2026 to $14.58B by 2035, driven by demand for minimally invasive procedures.

Stryker will announce first quarter fiscal 2026 results April 30, with webcast discussion at 4:30 p.m. ET following press release.

Boston Scientific shares fell 9% after Watchman FLX trial met all endpoints but disappointed investors seeking transformative clinical data to accelerate growth.

Stryker schedules virtual annual shareholder meeting for May 6, 2026, declares $0.88 quarterly dividend payable April 30, 2026.

Global orthobiologics market projected to grow 43% to $9.52B by 2031, driven by rising osteoarthritis and regenerative therapy advancements.

Stryker hit by suspected Iran-linked cyberattack wiping devices globally; stock falls 3.82% as company investigates with Microsoft.

Medical device cleaning market projected to nearly double to $3.74B by 2032, driven by stricter infection control regulations and shift toward reusable devices in healthcare.

Rigid endoscopes market to grow from $7.36B to $11.52B by 2033, driven by minimally invasive surgery demand and technological advances in imaging capabilities.

Fibrin sealant market to double from $1.60B to $3.57B by 2035, driven by surgical demand and minimally invasive techniques despite accessibility challenges in developing regions.

Global uterine fibroid treatment market projected to grow 7.63% annually through 2033, reaching $9.43 billion. Growth driven by high disease prevalence and minimally invasive surgical advances.